Case report: Enteral nutritional supplement as a likely cause of false-positive galactomannan testing

被引：13

作者：

Ng, Tong-Yong ^{[1
]}

Kang, Mei-Ling ^{[2
]}

Tani, Ban -Hock ^{[2
]}

Ngan, Cecilia Cheng-Lai ^{[3
]}

机构：

[1] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore

[2] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore

[3] Chang Gen Hosp, Dept Lab Med, Singapore, Singapore

来源：

MEDICAL MYCOLOGY CASE REPORTS | 2014年 / 3卷

关键词：

Galactomannan; False-positive; Nutritional supplement; Transplant;

D O I：

10.1016/j.mmcr.2013.11.004

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The detection of galactomannan (GM) in the serum of in immunocompromised patients is widely used for the early diagnosis of invasive aspergillosis. We report a case of a false-positive GM test presumably caused by the enteral nutritional supplement given to a non-neutropenic patient with intestinal graft versus-host disease after a hematopoietic stem cell transplant. Clinicians should be alert to the possibility of False-positive GM results in patients on nutritional supplements. (C) 2013 The Authors, International Society for Human and Animal Mycology. Published by Elsevier B.V.

引用

页码：11 / 13

页数：3

共 18 条

[1]

Aceti A, 2008, PEDIATR INFECT DIS J, V27, P769, DOI [10.1097/INF.0b013e31817c0b6e, 10.1097/INF.0b013e31817e840a]

[2] Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies [J].

Adam, O ;

Aupérin, A ;

Wilquin, F ;

Bourhis, JH ;

Gachot, B ;

Chachaty, E .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (06) :917-920

[3] Detection of Aspergillus galactomannan antigen in foods and antibiotics [J].

Ansorg, R ;

van den Boom, R ;

Rath, PM .

MYCOSES, 1997, 40 (9-10) :353-357

[4] Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients [J].

Barnes, R. A. ;

White, P. L. ;

Bygrave, C. ;

Evans, N. ;

Healy, B. ;

Kell, J. .

JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (01) :64-69

[5] Preparation and characterization of molecular weight fractions of guar galactomannans using acid and enzymatic hydrolysis [J].

Cheng, Y ;

Brown, KM ;

Prud'homme, RK .

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2002, 31 (1-3) :29-35

[6] Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid [J].

Hage, Chadi A. ;

Reynolds, John M. ;

Durkin, Michelle ;

Wheat, L. Joseph ;

Knox, Kenneth S. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (02) :676-677

[7] Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis [J].

Koo, Sophia ;

Bryar, Julie M. ;

Baden, Lindsey R. ;

Marty, Francisco M. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (04) :1255-1260

[8] Design issues in studies evaluating diagnostic tests for aspergillosis [J].

Marr, KA ;

Leisenring, W .

CLINICAL INFECTIOUS DISEASES, 2005, 41 :S381-S386

[9] Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis [J].

Mennink-Kersten, MASH ;

Donnelly, JP ;

Verweij, PE .

LANCET INFECTIOUS DISEASES, 2004, 4 (06) :349-357

[10] Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications [J].

Miceli, Marisa H. ;

Maertens, Johan ;

Buve, Kristel ;

Grazziutti, Monica ;

Woods, Gail ;

Rahman, Mazhar ;

Barlogie, Bart ;

Anaissie, Elias J. .

CANCER, 2007, 110 (01) :112-120

← 1 2 →